Nuvalent director Matthew Shair sells over $2.8 million in company stock

Published on 2 Apr 2024 on Investing.com

Nuvalent, Inc. ( NASDAQ :NUVL) Director Matthew Shair has recently sold a significant amount of the...

Read the rest of the article

Start tracking your investments with Statfolio

We recently compiled a list of the 10 Worst Cancer Stocks To Buy Now According to Short Sellers. ...

Insider Monkey · via Yahoo Finance 22 Sep 2024

We recently compiled a list of the 10 Largest Biotech Hedge Funds and Their Top Stock Picks. In t...

Insider Monkey · via Yahoo Finance 22 Sep 2024

Investors are always looking for stocks that are poised to beat at earnings season and Nuvalent, ...

Zacks via Yahoo Finance 6 May 2024

Nuvalent Inc (NASDAQ:NUVL), a company specializing in the development of precisely targeted thera...

GuruFocus.com via Yahoo Finance 5 Apr 2024

Few corners of the market have been as prone to dealmaking over the last couple of years as the l...

Investing.com 4 Apr 2024

Nuvalent, Inc. ( NASDAQ :NUVL) Director Matthew Shair has recently sold a significant amount of t...

Investing.com 2 Apr 2024

Nuvalent Inc (NASDAQ:NUVL), a company specializing in the development of precisely targeted thera...

GuruFocus.com via Yahoo Finance 30 Mar 2024

Nuvalent Inc (NASDAQ:NUVL), a company specializing in the development of precisely targeted thera...

GuruFocus.com via Yahoo Finance 25 Mar 2024

Nuvalent Inc (NASDAQ:NUVL), a company specializing in the development of precisely targeted thera...

GuruFocus.com via Yahoo Finance 19 Mar 2024

Nuvalent advances cancer drug trials, maintains strong cash position

Investing.com 27 Feb 2024